Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 09, 2018
ERT announced advanced respiratory clinical trial services that centrally collect lung function data using the FOT.
read more
Wednesday, March 24, 2021
PerkinElmer announced documentation, workflow and decision-making Signals informatics platform is being expanded to build on existing capabilities in the biologics drug discovery space.
read more
Wednesday, February 05, 2020
The FDA issued an emergency use authorization to enable emergency use of the CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel.
read more
Adare Pharmaceuticals has entered into an agreement with Egalet, to acquire global rights of the “Parvulet™” technology platform and its associated Intellectual Property.
read more
Thursday, October 31, 2013
Quality by Design (QbD) and its systematic approach to development begins with a predefined objective and emphasizes sound science and quality risk principles as an integral part of product development and process control implementation, and can help...
read more
Wednesday, January 16, 2019
Bioanalytical Systems announced the election of Robert Leasure, Jr., as President and Chief Executive Officer and as a director of the company, effective as of January 12, 2019.
read more
Thursday, September 15, 2022
The PPD clinical research business of Thermo Fisher Scientific has been awarded a 10-year Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract by the National Cancer Institute (NCI), part of the National Institutes of Health, to support NCI’s ...
read more
Thursday, November 19, 2015
Merck and Pfizer today have announced that the US Food and Drug Administration (FDA) has granted avelumab, an investigational fully human anti-PD-L1 IgG1 monoclonal antibody, Breakthrough Therapy designation for the treatment of patients with ...
read more
Thursday, November 09, 2023
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene ...
read more
Wednesday, January 10, 2024
Formerly known as Goodwin Biotechnology, GBI BioManufacturing has proudly announced the execution of its second Master Supply Agreement (MSA) to bring a radioimmunoconjugate product to the commercial market.
read more
Neovii has signed a research and license agreement with Tel Aviv University to develop a novel COVID-19 vaccine.
read more
Rokote Laboratories Finland Ltd and Exothera S.A. will collaborate to bring the intranasal coronavirus vaccine FINCoVac 2.0 to clinical Phase I/II trials. Exothera will finetune the industrialization of the FINCOVAC 2.0 process and manufacture ...
read more
Sen-Jam Pharmaceutical has executed a second strategic partnership with KVK Tech. KVK Tech is a Specialty Pharmaceutical Manufacturing company that will now be providing formulation and Chemistry, Manufacturing & Controls (CMC) for Sen-Jam ...
read more
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has agreed, subject to certain customary closing conditions (including applicable regulatory approvals), to ...
read more
Friday, September 23, 2016
Laboratory Corporation of America® Holdings (LabCorp®) has announced that veteran biopharmaceutical executive John Ratliff will succeed Deborah Keller as CEO of Covance Drug Development, effective October 1. Ratliff will be a member of the LabCorp ...
read more